[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Edwards Lifesciences Corp (EW)

Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 46,040,964
  • Shares Outstanding, K 575,800
  • Annual Sales, $ 6,068 M
  • Annual Income, $ 1,074 M
  • EBIT $ 1,347 M
  • EBITDA $ 1,504 M
  • 60-Month Beta 0.87
  • Price/Sales 7.85
  • Price/Cash Flow 29.02
  • Price/Book 4.62

Options Overview Details

View History
  • Implied Volatility 30.67% (+1.73%)
  • Historical Volatility 29.74%
  • IV Percentile 67%
  • IV Rank 44.90%
  • IV High 46.09% on 10/24/25
  • IV Low 18.11% on 08/28/25
  • Expected Move (DTE 5) 2.30 (2.87%)
  • Put/Call Vol Ratio 0.38
  • Today's Volume 432
  • Volume Avg (30-Day) 1,940
  • Put/Call OI Ratio 1.26
  • Today's Open Interest 56,862
  • Open Int (30-Day) 49,305
  • Expected Range 77.67 to 82.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.74
  • Number of Estimates 10
  • High Estimate $0.76
  • Low Estimate $0.72
  • Prior Year $0.67
  • Growth Rate Est. (year over year) +10.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
77.10 +3.71%
on 04/15/26
85.06 -5.99%
on 05/01/26
-1.75 (-2.14%)
since 04/08/26
3-Month
74.66 +7.10%
on 02/11/26
87.32 -8.43%
on 03/02/26
+1.25 (+1.59%)
since 02/06/26
52-Week
72.30 +10.59%
on 10/13/25
87.89 -9.02%
on 12/05/25
+5.33 (+7.14%)
since 05/08/25

Most Recent Stories

More News
Edwards Lifesciences Announces Appointment of CFO

Edwards Lifesciences (NYSE: EW) today announced the appointment of Theodora (“Doretta”) Mistras as the company’s corporate vice president and chief financial officer (CFO), effective at the end of...

EW : 79.96 (-3.38%)
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue

Edwards Lifesciences (NYSE: EW) today announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue. The data...

EW : 79.96 (-3.38%)
Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference

Edwards Lifesciences (NYSE: EW) today announced it will participate in the BofA Securities 2026 Health Care Conference on Tuesday, May 12, 2026. Bernard Zovighian, chief executive officer,...

EW : 79.96 (-3.38%)
S&P 500 and Nasdaq Post Record Highs on Tech Stock Strength and Iran Diplomacy

The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +0.80%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.95%. June E-mini...

AMAT : 435.44 (+6.04%)
CHE : 424.26 (-0.37%)
INTU : 396.31 (-2.57%)
HIMS : 28.27 (+10.21%)
BYD : 85.64 (+0.47%)
$IUXX : 29,234.99 (+2.35%)
ASML : 1,592.02 (+4.97%)
ZNM26 : 110-240s (+0.21%)
MSFT : 415.12 (-1.34%)
PFG : 100.50 (+0.47%)
ESM26 : 7,419.00s (+0.76%)
QCOM : 219.09 (+8.17%)
Stocks Rise on Intel’s Earnings and Possible Resumption of Iran Peace Talks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.41%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.36%. June E-mini S&P futures (ESM26...

AMAT : 435.44 (+6.04%)
CHE : 424.26 (-0.37%)
HIMS : 28.27 (+10.21%)
BYD : 85.64 (+0.47%)
$IUXX : 29,234.99 (+2.35%)
ASML : 1,592.02 (+4.97%)
ZNM26 : 110-240s (+0.21%)
PFG : 100.50 (+0.47%)
ESM26 : 7,419.00s (+0.76%)
QCOM : 219.09 (+8.17%)
AMD : 455.19 (+11.44%)
LRCX : 294.05 (+2.63%)
Stocks Supported by Intel’s Blowout Earnings and Iran Peace Talk Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up +0.27%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.34%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.10%. June E-mini S&P futures (ESM26...

AMAT : 435.44 (+6.04%)
CHE : 424.26 (-0.37%)
HIMS : 28.27 (+10.21%)
BYD : 85.64 (+0.47%)
$IUXX : 29,234.99 (+2.35%)
ASML : 1,592.02 (+4.97%)
ZNM26 : 110-240s (+0.21%)
ESM26 : 7,419.00s (+0.76%)
QCOM : 219.09 (+8.17%)
AMD : 455.19 (+11.44%)
LRCX : 294.05 (+2.63%)
LLY : 948.45 (-2.72%)
Edwards Lifesciences Reports First Quarter Results

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2026. Highlights and Outlook ...

EW : 79.96 (-3.38%)
Edwards Lifesciences: A Revenue Beat Won't Be Enough If Margins Stay Squeezed

Barchart Research What to Expect from EW Earnings EW Generated April 22, 2026 Current Price $81.53 EPS Estimate $$0.72 Consensus Rating Moderate Buy Average Move 7.22% Edwards Lifesciences: A Revenue Beat...

EW : 79.96 (-3.38%)
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2026 after the market closes on Thursday April 23, and will host a conference call at 5:00 p.m. ET...

EW : 79.96 (-3.38%)
Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits

TRISCEND II randomized trial data presented at ACC show lower mortality with EVOQUE system, when accounting for patient crossover

EW : 79.96 (-3.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair...

See More

Key Turning Points

3rd Resistance Point 86.05
2nd Resistance Point 84.55
1st Resistance Point 82.25
Last Price 79.96
1st Support Level 78.45
2nd Support Level 76.95
3rd Support Level 74.65

See More

52-Week High 87.89
Fibonacci 61.8% 81.93
Fibonacci 50% 80.10
Last Price 79.96
Fibonacci 38.2% 78.26
52-Week Low 72.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.